TWI865470B - 治療眼睛疾病之肽及醫藥組合物 - Google Patents
治療眼睛疾病之肽及醫藥組合物 Download PDFInfo
- Publication number
- TWI865470B TWI865470B TW108141290A TW108141290A TWI865470B TW I865470 B TWI865470 B TW I865470B TW 108141290 A TW108141290 A TW 108141290A TW 108141290 A TW108141290 A TW 108141290A TW I865470 B TWI865470 B TW I865470B
- Authority
- TW
- Taiwan
- Prior art keywords
- yde
- compound
- substituted
- pharmaceutically acceptable
- certain embodiments
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Ophthalmology & Optometry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Immunology (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862767180P | 2018-11-14 | 2018-11-14 | |
| US62/767,180 | 2018-11-14 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| TW202031675A TW202031675A (zh) | 2020-09-01 |
| TWI865470B true TWI865470B (zh) | 2024-12-11 |
Family
ID=70732068
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TW108141290A TWI865470B (zh) | 2018-11-14 | 2019-11-13 | 治療眼睛疾病之肽及醫藥組合物 |
Country Status (10)
| Country | Link |
|---|---|
| EP (1) | EP3880690A4 (enExample) |
| JP (1) | JP7522732B2 (enExample) |
| KR (1) | KR20210087539A (enExample) |
| CN (1) | CN113474356B (enExample) |
| AU (1) | AU2019378162B2 (enExample) |
| BR (1) | BR112021009341A2 (enExample) |
| MX (1) | MX2021005077A (enExample) |
| SG (1) | SG11202104178TA (enExample) |
| TW (1) | TWI865470B (enExample) |
| WO (1) | WO2020099925A2 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US12037415B2 (en) | 2017-05-17 | 2024-07-16 | Yuyu Pharma, Inc. | Peptide and pharmaceutical composition for treating an eye disease comprising the same as an active pharmaceutical ingredient |
| US11613558B2 (en) | 2018-11-14 | 2023-03-28 | Yuyu Pharma, Inc. | Peptides and pharmaceutical compositions for treating eye diseases |
| BR112021023477A2 (pt) | 2019-05-21 | 2022-02-15 | Eyebio Korea | Novo composto peptídico, composição farmacêutica para prevenir ou tratar inflamação, composição de alimento para prevenir ou amenizar a inflamação e composição de cosmético tendo um efeito anti inflamatório |
| WO2021191689A2 (en) * | 2020-03-05 | 2021-09-30 | Yuyu Pharma, Inc. | Treatment of inflammatory diseases with peptides and pharmaceutical compositions |
| MX2024006997A (es) * | 2021-12-13 | 2024-06-19 | Eyebiokorea Inc | Composicion para el tratamiento de la degeneracion macular que comprende un nuevo peptido. |
| KR102662922B1 (ko) * | 2022-05-31 | 2024-05-03 | 주식회사 세네릭스 | 신규의 d-아미노산 유도체 및 이를 포함하는 약학 조성물 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6037135A (en) * | 1992-08-07 | 2000-03-14 | Epimmune Inc. | Methods for making HLA binding peptides and their uses |
| KR101690539B1 (ko) * | 2015-07-30 | 2016-12-29 | 주식회사 아이바이오코리아 | 건성안 예방 또는 치료용 약학조성물 |
| ES2822289T3 (es) * | 2016-04-08 | 2021-04-30 | Eyebio Korea | Péptido a base de colágeno tipo II alfa-1 para su uso en el tratamiento de la degeneración macular |
| KR101795653B1 (ko) * | 2016-05-19 | 2017-11-09 | 인제대학교 산학협력단 | 콜라겐 타입 ii 펩타이드-아플리버셉트의 키메라 단백질을 유효성분으로 함유하는 혈관신생 억제용 조성물 |
| KR20180074928A (ko) * | 2016-12-26 | 2018-07-04 | 주식회사 아이바이오코리아 | 건성안 예방 또는 치료용 동물 의약품 조성물 |
| US12037415B2 (en) * | 2017-05-17 | 2024-07-16 | Yuyu Pharma, Inc. | Peptide and pharmaceutical composition for treating an eye disease comprising the same as an active pharmaceutical ingredient |
-
2019
- 2019-11-13 TW TW108141290A patent/TWI865470B/zh active
- 2019-11-14 SG SG11202104178TA patent/SG11202104178TA/en unknown
- 2019-11-14 WO PCT/IB2019/001220 patent/WO2020099925A2/en not_active Ceased
- 2019-11-14 CN CN201980078779.XA patent/CN113474356B/zh active Active
- 2019-11-14 MX MX2021005077A patent/MX2021005077A/es unknown
- 2019-11-14 BR BR112021009341-9A patent/BR112021009341A2/pt unknown
- 2019-11-14 KR KR1020217018226A patent/KR20210087539A/ko not_active Ceased
- 2019-11-14 JP JP2021526304A patent/JP7522732B2/ja active Active
- 2019-11-14 AU AU2019378162A patent/AU2019378162B2/en active Active
- 2019-11-14 EP EP19883897.1A patent/EP3880690A4/en active Pending
Non-Patent Citations (1)
| Title |
|---|
| 期刊 Lee et al., "Anti-inflammatory effect of hydroxyproline-GQDGLAGPK in desiccation stress-induced experimental dry eye mouse", Scientific Reports, 2017, 7, no.7413. |
Also Published As
| Publication number | Publication date |
|---|---|
| MX2021005077A (es) | 2021-08-11 |
| CN113474356A (zh) | 2021-10-01 |
| WO2020099925A3 (en) | 2020-06-25 |
| KR20210087539A (ko) | 2021-07-12 |
| EP3880690A2 (en) | 2021-09-22 |
| JP2022507404A (ja) | 2022-01-18 |
| SG11202104178TA (en) | 2021-05-28 |
| JP7522732B2 (ja) | 2024-07-25 |
| TW202031675A (zh) | 2020-09-01 |
| BR112021009341A2 (pt) | 2021-08-10 |
| EP3880690A4 (en) | 2023-09-13 |
| CN113474356B (zh) | 2024-12-17 |
| WO2020099925A2 (en) | 2020-05-22 |
| CA3119921A1 (en) | 2020-05-22 |
| AU2019378162B2 (en) | 2025-01-30 |
| AU2019378162A1 (en) | 2021-05-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7522732B2 (ja) | 眼疾患治療用のペプチド及び医薬組成物 | |
| JP7775250B2 (ja) | 新規ペプチド及びその新規ペプチドを活性成分として含む眼疾患の治療のための医薬組成物 | |
| CN114159430B (zh) | 作为免疫调节剂的1,2,4-噁二唑和噻二唑化合物 | |
| CN107405336A (zh) | 作为免疫调节剂的1,3,4‑噁二唑和噻二唑化合物 | |
| TW201043623A (en) | Crystalline tripeptide epoxy ketone protease inhibitors | |
| WO2021191689A2 (en) | Treatment of inflammatory diseases with peptides and pharmaceutical compositions | |
| WO2024008044A1 (zh) | 大环拟肽类蛋白酶抑制剂及其用途 | |
| US20230312648A1 (en) | Peptides and pharmaceutical compositions for treating eye diseases | |
| TW201718548A (zh) | 哌嗪（ｐｉｐｅｒａｚｉｎｅ）衍生物 | |
| RU2819399C2 (ru) | Пептиды и фармацевтические композиции для лечения глазных болезней | |
| CA3119921C (en) | Peptides and pharmaceutical compositions for treating eye diseases | |
| HK40061089B (en) | Peptides and pharmaceutical compositions for treating eye diseases | |
| HK40061089A (en) | Peptides and pharmaceutical compositions for treating eye diseases | |
| HK40017864A (en) | Novel peptide and pharmaceutical composition for treatment of eye diseases comprising same novel peptide as active ingredient |